Henry Schein 2026 Q1: Global Dental Distribution Business Revenue Reaches $1.766 Billion, Up 9.0% Year-over-Year

Source: Henry Schein 2026 First Quarter Financial Performance Report

DentalGoodNews｜On May 5, 2026, Henry Schein, Inc. released its first-quarter 2026 financial report. The report shows that total revenue in the first quarter reached $3.368 billion (approximately RMB 22.936 billion), a year-over-year increase of 6.3%.

In terms of profitability, GAAP net profit attributable to shareholders of the parent company for the quarter was $107 million (approximately RMB 729 million), down 2.3% year-over-year; GAAP diluted earnings per share (EPS) was $0.92 (approximately RMB 6.27), up 4.5% year-over-year. Non-GAAP net income attributable to Henry Schein was $153 million (approximately RMB 1.042 billion), up 6.5% year-over-year; non-GAAP diluted EPS was $1.32 (approximately RMB 8.99), up 14.8% year-over-year. The difference between GAAP and non-GAAP net income was primarily driven by $12 million (approximately RMB 81.72 million) in restructuring costs and $45 million (approximately RMB 306 million) in amortization of acquired intangible assets.

Source: Henry Schein 2026 First Quarter Financial Performance Report

By business segment, Global Dental Distribution revenue was $1.766 billion (approximately RMB 12.026 billion), up 9.0% year-over-year. Within this, Dental Consumables revenue was $1.292 billion (approximately RMB 8.799 billion), up 9.0% year-over-year; Dental Equipment revenue was $417 million (approximately RMB 2.840 billion), up 8.6% year-over-year; Global Value-Added Services revenue was $57 million (approximately RMB 388 million), up 10.6% year-over-year.

Global Medical Distribution revenue was $1.073 billion (approximately RMB 7.307 billion), up 1.7% year-over-year. Global Specialty Products revenue was $397 million (approximately RMB 2.704 billion), up 8.1% year-over-year; Global Technology revenue was $173 million (approximately RMB 1.178 billion), up 7.0% year-over-year.

Source: Henry Schein 2026 First Quarter Financial Performance Report

In terms of international market performance, combined revenue from International Distribution and Value-Added Services was $930 million (approximately RMB 6.333 billion), up 13.1% year-over-year, with foreign exchange contributing 9.8% of the growth. The financial report did not separately disclose specific revenue data for the Chinese market.

During the quarter, the company also acquired a controlling stake in the U.S. distributor of S.I.N. Dental Implants to strengthen its position in the value implant market and support its business integration strategy. This transaction resulted in a remeasurement gain of $11 million (approximately RMB 74.91 million).

Source: Henry Schein 2026 First Quarter Financial Performance Report

In terms of cash flow, Henry Schein reported a net operating cash outflow of $97 million (approximately RMB 661 million) for the quarter, a significant shift from a net inflow of $37 million (approximately RMB 252 million) in the same period last year, primarily due to changes in accounts payable and accrued expenses. Additionally, the company spent $125 million (approximately RMB 851 million) during the quarter to repurchase approximately 1.6 million shares of common stock. As of the end of the quarter, the company had $655 million (approximately RMB 4.461 billion) authorized and available for future share repurchases.

Looking ahead to the full year 2026, Henry Schein expects total sales to grow by 3% to 5%, with non-GAAP diluted EPS projected to be between $5.23 (approximately RMB 35.62) and $5.37 (approximately RMB 36.57). Adjusted EBITDA for 2026 remains unchanged, with expectations of mid-single-digit growth compared to 2025. Additionally, the company confirmed that its value creation plan is expected to cumulatively generate over $200 million (approximately RMB 1.362 billion) in revenue growth over the next several years, with an annualized growth rate reaching $125 million (approximately RMB 851 million) by the end of 2026.